| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2731 |
| Trial ID | NCT04960579 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | P-BCMA-ALLO1 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma |
| Year | 2021 |
| Country | United States |
| Company sponsor | Poseida Therapeutics, Inc. |
| Other ID(s) | P-BCMA-ALLO1-001 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||